Resumen
The development of a transmission-blocking vaccine (TBV) against malaria is hampered by poor understanding of functional antibody responses. In this issue of Immunity, Fabra-Garcia et al., Ivanochko et al., and Tang et al. isolate human monoclonal antibodies against the two most promising TBV candidates, Pfs48/45 and Pfs230, and map the epitopes responsible for potent transmission-reducing activity.
Idioma original | English (US) |
---|---|
Páginas (desde-hasta) | 234-236 |
Número de páginas | 3 |
Publicación | Immunity |
Volumen | 56 |
N.º | 2 |
DOI |
|
Estado | Published - feb 14 2023 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases